Medical, Scientific, and Regulatory Updates
MIKS curates reliable and high-quality information published in the field of regenerative medicine, ensuring you can effortlessly stay current.
Certain news pieces are exclusively available to members. If you wish for unrestricted access to all news articles, you can achieve that by becoming a member of our community. Join as a member today to enjoy complete access to all our content.
-
MIKS NEWS
The 1st International MiKS Congress will bring the latest in Biological Therapies to Vitoria – Gasteiz (Spain)
From April 3 to 5, 2025, Vitoria-Gasteiz will be the meeting point for the main international references in biological therapies. This congress will bring together experts in orthopedic surgery, sports medicine and pain management, among others, to explore the latest advances in blood derivatives and cell therapies.
January 06, 2025
-
BASIC RESEARCH
Effects of intramuscular administration of Platelet-Rich Plasma on denervated muscle after peripheral nerve injury
Peripheral nerve injuries (PNI) are common, with more than one million cases annually worldwide, resulting in loss of motor and sensory function and muscle atrophy due to prolonged denervation.
December 27, 2024
-
MIKS NEWS
New developments in platelet-rich plasma (PRP): new advances in the integration of extraplatelet molecules to improve its therapeutic efficacy.
This development represents a crucial step towards more effective and personalized treatments in the field of tissue regeneration.
December 16, 2024
-
BASIC RESEARCH
Current Challenges in the Development of Platelet-Rich Plasma-Based Therapies
Biological therapies are booming and more of these formulations are coming to the market as well as novel systems for the production of PRPs.
September 02, 2024
-
SCIENTIFIC HIGHLIGHTS
Europe improves early access to clinical trial information
The Clinical Trials Information System (CTIS), managed by the European Medicines Agency (EMA), has been updated to allow earlier and more efficient access to information on clinical trials in the EU.
August 09, 2024
-
SCIENTIFIC HIGHLIGHTS
Platelet-rich plasma injections for the management of knee osteoarthritis: The ESSKA-ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios
July 04, 2024
-
SCIENTIFIC HIGHLIGHTS
A systematic review of preclinical evidence by the ESSKA Innitiative on corticosteroid injections for the treatment of OA
Analyzing 32 studies in animal models (1079 joints), it was found that CS injections showed positive effects in 68% of the studies and detrimental effects in 16%.
July 01, 2024
-
MIKS NEWS
Dr. Mikel Sánchez, recognized by TOBI, the world's leading congress on regenerative medicine
This international award recognizes all those who have worked tirelessly for the development, preservation and advancement of Regenerative Medicine through their leadership, clinical research and dedication.
June 24, 2024
-
SCIENTIFIC HIGHLIGHTS
Use of injectable orthobiologics for the treatment of knee osteoarthritis. ESSKA ORBIT Consensus
After several years of work, the consensus reached by leading European experts in sports traumatology, knee surgery and arthroscopy has recently been published, shedding light on promising treatment options for knee osteoarthritis (KOA).
April 26, 2024
-
BASIC RESEARCH
Method to obtain a plasma rich in platelet- and plasma-growth factors based on water evaporation
In the present work, published by the journal PLOS ONE, a novel PRP preparation method has been developed to obtain PRP rich in both platelet and extraplatelet molecules by evaporation of plasma water. The PRP obtained by this method showed promising results in vitro as an enhanced PRP treatment for future application.
February 21, 2024
-
CLINICAL RESEARCH
Women show a positive response to Platelet-Rich Plasma despite presenting more painful knee osteoarthritis than men
The purpose of this study, published on February 2024 in Knee Surgery, Sports Traumatology, Arthroscopy, was to evaluate the impact of gender on the efficacy of Platelet-Rich Plasma (PRP) in patients with knee osteoarthritis (KOA), comparing the short-term response of men and women.
February 16, 2024
-
BASIC RESEARCH
New Formulations of Platelet-Rich Plasma: The Relevance of Extraplatelet Molecules
Recently, alternative collection systems have been developed based on methods such as filtration, sedimentation, ultrasound, microfluidics and water absorption. Some of these systems also favor the enrichment of extraplatelet components, which may offer additional advantages.
January 19, 2024
